NERV (Minerva Neurosciences) FCF Margin %: 0.00% (As of Mar. 2026)


NERV Minerva Neurosciences Inc NERV
32 GF Score
Price $4.32
! 1 Warning Sign
View Full Analysis

What is Minerva Neurosciences FCF Margin %?

Minerva Neurosciences NERV -0.23% 32 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NERV with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 960 Biotechnology companies, Minerva Neurosciences ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Minerva Neurosciences's Free Cash Flow for the three months ended in Mar. 2026 was $-5.43 Mil. Minerva Neurosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Minerva Neurosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Minerva Neurosciences's current FCF Yield % is -7.39%.

The historical rank and industry rank for Minerva Neurosciences's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Minerva Neurosciences was -82.14%. The lowest was -82.14%. And the median was -82.14%.

NERV's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Minerva Neurosciences FCF Margin % Related Terms

Minerva Neurosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Minerva Neurosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Neurosciences FCF Margin % Chart

Minerva Neurosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Minerva Neurosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NERV vs YDES, CAMP, IKT: FCF Margin % Comparison

For the Biotechnology subindustry, Minerva Neurosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minerva Neurosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Minerva Neurosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Minerva Neurosciences's FCF Margin % falls into.


NERV
32GF Score
Minerva Neurosciences Inc NERV
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minerva Neurosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Minerva Neurosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.511/0
= %

Minerva Neurosciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.427/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Minerva Neurosciences (NERV) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Minerva Neurosciences and its competitors. According to the industry distribution chart, Minerva Neurosciences ranks #999999 out of 960 companies in the Biotechnology industry.
Is Minerva Neurosciences' FCF Margin % too high?
Minerva Neurosciences' current FCF Margin % is 0.00%. Based on the distribution chart, Minerva Neurosciences ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Minerva Neurosciences has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Minerva Neurosciences' FCF Margin % compare to YDES and CAMP?
According to the Biotechnology industry distribution chart, Minerva Neurosciences ranks #999999 out of 960 companies for FCF Margin %. This places Minerva Neurosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Minerva Neurosciences and its competitors. Minerva Neurosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Neurosciences stock overvalued right now?
Minerva Neurosciences (NERV) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Minerva Neurosciences' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Minerva Neurosciences (NERV), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Neurosciences Business Description

Other Exchanges 4MNA:Germany
Address 1500 District Avenue, Burlington, MA, USA, 01803
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
32GF Score

Get the complete analysis for NERV

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.32
Price